13-113424278-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001394807.1(ADPRHL1):c.846C>T(p.Asp282=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00292 in 1,612,950 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.016 ( 59 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 55 hom. )
Consequence
ADPRHL1
NM_001394807.1 synonymous
NM_001394807.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.999
Genes affected
ADPRHL1 (HGNC:21303): (ADP-ribosylhydrolase like 1) ADP-ribosylation is a reversible posttranslational modification used to regulate protein function. ADP-ribosyltransferases (see ART1; MIM 601625) transfer ADP-ribose from NAD+ to the target protein, and ADP-ribosylhydrolases, such as ADPRHL1, reverse the reaction (Glowacki et al., 2002 [PubMed 12070318]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 13-113424278-G-A is Benign according to our data. Variant chr13-113424278-G-A is described in ClinVar as [Benign]. Clinvar id is 717321.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.999 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0524 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADPRHL1 | NM_001394807.1 | c.846C>T | p.Asp282= | synonymous_variant | 6/8 | ENST00000612156.3 | NP_001381736.1 | |
ADPRHL1 | NM_138430.5 | c.846C>T | p.Asp282= | synonymous_variant | 6/7 | NP_612439.2 | ||
ADPRHL1 | NM_199162.3 | c.600C>T | p.Asp200= | synonymous_variant | 6/7 | NP_954631.1 | ||
ADPRHL1 | XM_047430086.1 | c.600C>T | p.Asp200= | synonymous_variant | 6/8 | XP_047286042.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADPRHL1 | ENST00000612156.3 | c.846C>T | p.Asp282= | synonymous_variant | 6/8 | 5 | NM_001394807.1 | ENSP00000489048 | ||
ADPRHL1 | ENST00000375418.8 | c.846C>T | p.Asp282= | synonymous_variant | 6/7 | 1 | ENSP00000364567 | P1 | ||
ADPRHL1 | ENST00000356501.8 | c.600C>T | p.Asp200= | synonymous_variant | 6/7 | 1 | ENSP00000348894 |
Frequencies
GnomAD3 genomes AF: 0.0155 AC: 2356AN: 152158Hom.: 58 Cov.: 32
GnomAD3 genomes
AF:
AC:
2356
AN:
152158
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00427 AC: 1068AN: 250166Hom.: 23 AF XY: 0.00324 AC XY: 439AN XY: 135680
GnomAD3 exomes
AF:
AC:
1068
AN:
250166
Hom.:
AF XY:
AC XY:
439
AN XY:
135680
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00160 AC: 2343AN: 1460674Hom.: 55 Cov.: 31 AF XY: 0.00136 AC XY: 990AN XY: 726626
GnomAD4 exome
AF:
AC:
2343
AN:
1460674
Hom.:
Cov.:
31
AF XY:
AC XY:
990
AN XY:
726626
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0155 AC: 2363AN: 152276Hom.: 59 Cov.: 32 AF XY: 0.0145 AC XY: 1083AN XY: 74460
GnomAD4 genome
AF:
AC:
2363
AN:
152276
Hom.:
Cov.:
32
AF XY:
AC XY:
1083
AN XY:
74460
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 06, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at